Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biote Corp BTMD

Consumer Defensive Financial Services Education & Training Services
biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that... see more

Recent & Breaking News (NDAQ:BTMD)

Biote Formalizes Commitment to Men's Hormone Health With Launch of New Men's Health Division

Business Wire June 22, 2023

Biote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Warrants

Business Wire June 8, 2023

Biote Announces Pricing of Secondary Offering of Common Stock

Business Wire June 5, 2023

Biote to Participate at Upcoming Investor Conferences

Business Wire May 31, 2023

Biote Appoints Mary J. Puncochar as Chief Commercial Officer

Business Wire May 30, 2023

Biote Announces Commencement of Exchange Offer and Consent Solicitation Relating to Warrants

Business Wire May 9, 2023

Biote Reports First Quarter 2023 Financial Results

Business Wire May 9, 2023

Biote Schedules First Quarter 2023 Financial Results Release and Conference Call

Business Wire April 26, 2023

Biote Names John Denne as General Manager, Men's Health Division

Business Wire April 10, 2023

Biote Reports Fourth Quarter and Full Year 2022 Financial Results

Business Wire March 28, 2023

Study: Testosterone Pellet Therapy Significantly Improves Bone Density in Male Patient Case Report

Business Wire March 27, 2023

Biote to Present at 35th Annual Roth Conference

Business Wire March 2, 2023

Biote Schedules Fourth Quarter and Full Year 2022 Financial Results Release and Conference Call

Business Wire February 9, 2023

Biote Announces Closing of Secondary Offering of 8,500,000 Shares of Common Stock Including Full Exercise of the Underwriters' Over-Allotment Option

Business Wire January 9, 2023

Biote Announces Pricing of Secondary Offering of Common Stock

Business Wire January 5, 2023

Biote to Present at Jefferies London Healthcare Conference

Business Wire November 10, 2022

Biote Reports Third Quarter Financial Results

Business Wire November 8, 2022

Biote Appoints Debby Morris to Board of Directors

Business Wire November 7, 2022

Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call

Business Wire October 31, 2022

Biote Releases Updated Corporate Presentation for October 2022

Business Wire October 10, 2022